Is a complete PYXS research report available?

No complete published report is available for Pyxis Oncology, Inc. (PYXS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Pyxis Oncology, Inc. (PYXS)

NASDAQ: PYXS · USD

$1.98

+0.14 (+7.6%)· Recorded snapshot

Market cap	236.5M
Revenue (ttm)	11M
Net income (ttm)	-88.7M
EPS (ttm)	-$1.40
Shares out	119.5M
Volume	676,430
Beta	1.38

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 11M
Net income (ttm): -88.7M
EPS (ttm): -$1.40
Market cap: 236.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0001782223
Company name	Pyxis Oncology, Inc.
Country	United States
Country code	US
CUSIP number	747324101
Earnings date	2026-11-10
Earnings time	bmo
Employees	56
Employees change	12
Employees growth	27.27%
Enterprise value	$221.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
Industry	Biotechnology
IPO date	2021-10-01
Is primary listing	Yes
Is SPAC	No
ISIN number	US7473241013
Last 10-K release date	2026-03-23
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$236.5M
Market cap category	Micro-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$1.98
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	PYXS
U.S. state	Massachusetts
Website	https://www.pyxisoncology.com

Metric

Value

Amount currency

USD

CIK code

0001782223

Company name

Pyxis Oncology, Inc.

Country

United States

Country code

CUSIP number

747324101

Earnings date

2026-11-10

Earnings time

bmo

Employees

Employees change

Employees growth

27.27%

Enterprise value

$221.4M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2018

Industry

Biotechnology

IPO date

2021-10-01

Is primary listing

Yes

Is SPAC

ISIN number

US7473241013

Last 10-K release date

2026-03-23

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$236.5M

Market cap category

Micro-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$1.98

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

PYXS

U.S. state

Massachusetts

Website

https://www.pyxisoncology.com

Metric	Value
Earnings yield	-70.85%
EV/Sales	19.24x
FCF / EV yield	-31.98%
FCF yield	-29.85%
Forward EV/Sales	10,925.91x
Forward P/S	11,705.95x
P/B ratio	10.2x
P/S ratio	20.62x
Price / tangible book value	19.89x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-70.85%

EV/Sales

19.24x

FCF / EV yield

-31.98%

FCF yield

-29.85%

Forward EV/Sales

10,925.91x

Forward P/S

11,705.95x

P/B ratio

10.2x

P/S ratio

20.62x

Price / tangible book value

19.89x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Gross margin	78.37%
Operating margin	-812.74%
Pretax margin	-793.84%
Profit per employee	$-1.6M
Revenue per employee	$197,107
ROA	-62.95%
ROA (5Y)	-30.69%
ROCE	-326.84%
ROE	-179.1%
ROE (5Y)	-63.93%
ROIC	-82.23%
SBC / revenue	107.75%
Tax / revenue	9.99%

Metric

Value

Gross margin

78.37%

Operating margin

-812.74%

Pretax margin

-793.84%

Profit per employee

$-1.6M

Revenue per employee

$197,107

ROA

-62.95%

ROA (5Y)

-30.69%

ROCE

-326.84%

ROE

-179.1%

ROE (5Y)

-63.93%

ROIC

-82.23%

SBC / revenue

107.75%

Tax / revenue

9.99%

Metric	Value
EPS growth years	5
Gross profit growth	206.74%
Net income growth years	0
Revenue growth	291.42%
Revenue growth years	0

Metric

Value

EPS growth years

Gross profit growth

206.74%

Net income growth years

Revenue growth

291.42%

Revenue growth years

Metric	Value
Capital expenditures	$-9,000
Depreciation and amortization	$4.2M
EBIT	$-89.7M
EBITDA	$-85.5M
EPS	$-1.40
FCF per share	$-0.57
Financing cash flow	$10.6M
Free cash flow	$-67.9M
Free cash flow minus SBC	$-79.8M
Gross profit	$8.7M
Income taxes	$1.1M
Investing cash flow	$65.4M
Net cash flow	$8.1M
Net income	$-88.7M
Operating cash flow minus SBC	$-79.8M
Operating income	$-89.7M
Revenue	$11M
Stock-based compensation	$11.9M

Metric

Value

Capital expenditures

$-9,000

Depreciation and amortization

$4.2M

EBIT

$-89.7M

EBITDA

$-85.5M

EPS

$-1.40

FCF per share

$-0.57

Financing cash flow

$10.6M

Free cash flow

$-67.9M

Free cash flow minus SBC

$-79.8M

Gross profit

$8.7M

Income taxes

$1.1M

Investing cash flow

$65.4M

Net cash flow

$8.1M

Net income

$-88.7M

Operating cash flow minus SBC

$-79.8M

Operating income

$-89.7M

Revenue

$11M

Stock-based compensation

$11.9M

Metric	Value
Altman Z-Score	-15.71
Book value per share	$0.18
Debt / equity	1.56
Long-term assets	$18.2M
Long-term liabilities	$16M
Net cash (debt)	$15.2M
Net cash / market cap	6.66%
Net cash growth	-78.18%
Net debt / equity	-1.33
Piotroski F-Score	2
Property, plant and equipment	$18.2M
Shareholders' equity	$11.4M
Tangible book value	$11.4M
Tangible book value per share	$0.18
Total assets	$54.9M
Total cash	$33M
Total debt	$17.8M
Total liabilities	$43.5M
WACC	10.97%

Metric

Value

Altman Z-Score

-15.71

Book value per share

$0.18

Debt / equity

1.56

Long-term assets

$18.2M

Long-term liabilities

$16M

Net cash (debt)

$15.2M

Net cash / market cap

6.66%

Net cash growth

-78.18%

Net debt / equity

-1.33

Piotroski F-Score

Property, plant and equipment

$18.2M

Shareholders' equity

$11.4M

Tangible book value

$11.4M

Tangible book value per share

$0.18

Total assets

$54.9M

Total cash

$33M

Total debt

$17.8M

Total liabilities

$43.5M

WACC

10.97%

Metric	Value
Asset turnover	0.12
Current assets	$36.7M
Current liabilities	$27.5M
Current ratio	1.34
Net working capital	$-21.9M
Quick ratio	1.2
Working capital	$9.3M
Working capital turnover	0.24

Metric

Value

Asset turnover

0.12

Current assets

$36.7M

Current liabilities

$27.5M

Current ratio

1.34

Net working capital

$-21.9M

Quick ratio

1.2

Working capital

$9.3M

Working capital turnover

0.24

Metric	Value
Buyback yield / dilution	-3.27%
Dividend yield	0%
Shareholder yield	-3.27%

Metric

Value

Buyback yield / dilution

-3.27%

Dividend yield

Shareholder yield

-3.27%

Metric	Value
150-day SMA	$2.37
1D price change	7.61%
1M price change	-33.22%
1M total return	-33.22%
1W price change	3.8%
1W total return	3.8%
1Y price change	-43.66%
1Y return CAGR	-43.68%
1Y total return	-43.66%
20-day SMA	$1.90
200-day SMA	$2.16
3M price change	-34.36%
3M total return	-34.36%
3Y price change	21.66%
3Y return CAGR	6.75%
3Y total return	21.66%
50-day SMA	$2.71
50-day SMA vs 200-day SMA	50over200
52-week high	$5.55
52-week high date	2025-11-26
52-week low	$1.03
52-week low date	2025-12-26
5Y price change	-85.3%
5Y return CAGR	-31.85%
5Y total return	-85.3%
6M price change	8.52%
6M total return	8.52%
All-time high	$19.00
All-time high date	2021-10-08
All-time low	$0.83
All-time low date	2025-04-07
Average true range (ATR)	$0.17
Average volume	1.1M
Beta (1Y)	2.91
Beta (2Y)	1.68
Beta (5Y)	1.38
Change from 52-week high	-64.32%
Change from 52-week low	92.23%
Change from all-time high	-89.95%
Change from all-time low	129.24%
Change from open	7.03%
Day's gap	0.54%
Dollar volume	$1.3M
High price	$1.98
Low price	$1.81
Monthly RSI	45.97
Open price	$1.85
Position in 52-week range	100%
Premarket change	1.63%
Premarket close	$1.84
Premarket price	$1.87
Premarket volume	18K
Previous close	$1.84
Price vs 150-day SMA	-19.41%
Price vs 20-day SMA	0.69%
Price vs 200-day SMA	-11.53%
Price vs 50-day SMA	-29.55%
Relative volume	0.64
Return from IPO price	-88.09%
RSI	40.67
Sharpe ratio	0.18
Sharpe ratio (3Y)	0.57
Sharpe ratio (5Y)	0.12
Sortino ratio	0.3
Sortino ratio (3Y)	0.91
Sortino ratio (5Y)	0.24
Volume	676.4K
Weekly RSI	44.29
YTD price change	66.09%
YTD total return	66.09%

Metric

Value

150-day SMA

$2.37

1D price change

7.61%

1M price change

-33.22%

1M total return

-33.22%

1W price change

3.8%

1W total return

3.8%

1Y price change

-43.66%

1Y return CAGR

-43.68%

1Y total return

-43.66%

20-day SMA

$1.90

200-day SMA

$2.16

3M price change

-34.36%

3M total return

-34.36%

3Y price change

21.66%

3Y return CAGR

6.75%

3Y total return

21.66%

50-day SMA

$2.71

50-day SMA vs 200-day SMA

50over200

52-week high

$5.55

52-week high date

2025-11-26

52-week low

$1.03

52-week low date

2025-12-26

5Y price change

-85.3%

5Y return CAGR

-31.85%

5Y total return

-85.3%

6M price change

8.52%

6M total return

8.52%

All-time high

$19.00

All-time high date

2021-10-08

All-time low

$0.83

All-time low date

2025-04-07

Average true range (ATR)

$0.17

Average volume

1.1M

Beta (1Y)

2.91

Beta (2Y)

1.68

Beta (5Y)

1.38

Change from 52-week high

-64.32%

Change from 52-week low

92.23%

Change from all-time high

-89.95%

Change from all-time low

129.24%

Change from open

7.03%

Day's gap

0.54%

Dollar volume

$1.3M

High price

$1.98

Low price

$1.81

Monthly RSI

45.97

Open price

$1.85

Position in 52-week range

100%

Premarket change

1.63%

Premarket close

$1.84

Premarket price

$1.87

Premarket volume

18K

Previous close

$1.84

Price vs 150-day SMA

-19.41%

Price vs 20-day SMA

0.69%

Price vs 200-day SMA

-11.53%

Price vs 50-day SMA

-29.55%

Relative volume

0.64

Return from IPO price

-88.09%

RSI

40.67

Sharpe ratio

0.18

Sharpe ratio (3Y)

0.57

Sharpe ratio (5Y)

0.12

Sortino ratio

0.3

Sortino ratio (3Y)

0.91

Sortino ratio (5Y)

0.24

Volume

676.4K

Weekly RSI

44.29

YTD price change

66.09%

YTD total return

66.09%

Metric	Value
Float	78.3M
Float percentage	65.58%
Shares change (QoQ)	0.82%
Shares change (YoY)	3.27%
Shares held by insiders	3.56%
Shares held by institutions	14.49%
Shares outstanding	119.5M
Short % of float	6.24%
Short % of shares	4.09%
Short ratio	4 days

Metric

Value

Float

78.3M

Float percentage

65.58%

Shares change (QoQ)

0.82%

Shares change (YoY)

3.27%

Shares held by insiders

3.56%

Shares held by institutions

14.49%

Shares outstanding

119.5M

Short % of float

6.24%

Short % of shares

4.09%

Short ratio

4 days

Pyxis Oncology, Inc. (PYXS)

Price

Financial snapshot

Fair-value bridge

Latest news · PYXS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PYXS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PYXS

Frequently asked questions